Upcoming events on GSK PLC |
|
08/18/22 | | Ex-dividend day for interim dividend |
09/16/22 | | Bank of America Healthcare Conference |
11/02/22 | | Q3 2022 Earnings Release |
02/01/23 | | FY 2022 Earnings Release |
04/26/23 | | Q1 2023 Earnings Release (Projected) |
07/26/23 | | Interim 2023 Earnings Release (Projected) |
11/01/23 | | Q3 2023 Earnings Release (Projected) |
02/07/24 | | FY 2023 Earnings Release (Projected) |
|
|
07/27/22 | 07:00am | | Interim 2022 Earnings Call |
07/27/22 | 02:00am | | Interim 2022 Earnings Release |
07/19/22 | | REVERSE SPLIT: 4 of 5 |
07/19/22 | | REVERSE SPLIT: 4 of 5 |
07/18/22 | | Spin off |
07/18/22 | | Spin off |
07/06/22 | 09:30am | | Shareholders Meeting |
06/14/22 | 09:45am | | Deutsche Bank dbAccess Global Consumer Conference |
06/13/22 | 05:00pm | | Goldman Sachs Global Healthcare Conference |
05/24/22 | 09:15am | | UBS Global Healthcare Conference |
|
Past dividends on GSK PLC |
|
08/18/22 | | Interim Payment 0.1625 GBP |
05/19/22 | | Interim Payment 0.14 GBP |
02/24/22 | | Final Payment 0.23 GBP |
11/18/21 | | Interim Payment 0.19 GBP |
08/19/21 | | Interim Payment 0.19 GBP |
05/20/21 | | Interim Payment 0.19 GBP |
02/18/21 | | Final Payment 0.23 GBP |
11/12/20 | | Interim Payment 0.19 GBP |
08/13/20 | | Interim Payment 0.19 GBP |
05/14/20 | | Interim Payment 0.19 GBP |
|
|
Fiscal Period : December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
Sales M GBP |
Released Forecast Spread | 30 186 30 092 0,31% | 30 821 30 564 0,84% | 33 754 33 382 1,1% | 34 099 34 076 0,07% | 34 114 34 029 0,25% | 29 306 |
Operating income (EBITDA) M GBP |
Released Forecast Spread | 10 270 10 224 0,45% | 10 508 10 277 2,2% | 11 968 11 155 7,3% | 9 530 10 575 -9,9% | 11 330 10 048 13% | 9 075 |
Operating profit (EBIT) M GBP |
Released Forecast Spread | 8 568 8 576 -0,10% | 8 745 8 605 1,6% | 8 972 9 182 -2,3% | 8 906 8 955 -0,55% | 8 806 8 717 1,0% | 7 852 |
Pre-Tax Profit (EBT) M GBP |
Released Forecast Spread | 3 525 4 806 -27% | 4 800 5 259 -8,7% | 6 221 5 926 5,0% | 6 968 6 763 3,0% | 5 442 5 794 -6,1% | 5 873 |
Net income M GBP |
Released Forecast Spread | 1 532 3 279 -53% | 3 623 3 540 2,4% | 4 645 4 026 15% | 5 749 4 894 17% | 4 385 3 990 9,9% | 4 411 |
EPS GBP |
Released Forecast Spread | 0,39 0,85 -55% | 0,92 0,90 2,8% | 1,16 1,06 9,7% | 1,43 1,21 18% | 1,08 1,02 6,3% | 1,06 | Announcement Date | 02/07/2018 | 02/06/2019 | 02/05/2020 | 02/03/2021 | 02/09/2022 | - |
|
|
Fiscal Period : December | 2020 Q2 | 2020 Q3 | 2020 Q4 | 2021 Q1 | 2021 Q2 | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 |
Sales M GBP |
Released Forecast Spread | 7 624 7 734 -1,4% | 8 646 8 697 -0,59% | 8 739 8 715 0,28% | 7 418 7 888 -6,0% | 8 092 7 581 6,7% | 9 077 8 692 4,4% | 9 527 9 547 -0,21% | 9 780 9 145 6,9% | 6 929 6 906 0,33% | 7 287 | 7 130 | 5 865 | 6 642 | 7 540 |
Operating income (EBITDA) M GBP |
Released Forecast Spread | 2 526 2 339 8,0% | 2 024 2 919 -31% | 2 111 2 478 -15% | 2 041 2 307 -12% | 2 822 2 198 28% | 3 860 2 751 40% | 2 406 2 392 0,58% | 3 317 2 850 16% | 2 639 2 138 23% | 2 534 | 1 744 |
|
|
|
Operating profit (EBIT) M GBP |
Released Forecast Spread | 1 749 1 759 -0,59% | 2 665 2 343 14% | 1 817 1 920 -5,3% | 1 881 1 835 2,5% | 2 158 1 735 24% | 2 874 2 261 27% | 1 893 1 885 0,41% | 2 613 2 291 14% | 2 008 1 740 15% | 2 189 | 1 453 | 1 761 | 1 697 | 2 410 |
Pre-Tax Profit (EBT) M GBP |
Released Forecast Spread | 2 641 4 477 -41% | 1 671 1 676 -0,27% | 821 869 -5,5% | 1 518 967 57% | 1 470 1 086 35% | 1 748 1 423 23% | 706 812 -13% | 2 598 2 268 15% | 896 1 243 -28% |
|
|
|
|
|
Net income M GBP |
Released Forecast Spread | 2 263 1 718 32% | 1 244 878 42% | 677 162 317% | 1 073 534 101% | 1 395 519 169% | 1 168 836 40% | 749 122 516% | 1 802 1 674 7,7% | 975 802 22% | 1 263 | 664 |
|
|
|
EPS GBP |
Released Forecast Spread | 0,57 0,43 33% | 0,31 0,22 44% | 0,17 0,01 2 423% | 0,27 0,15 73% | 0,35 0,13 173% | 0,29 0,24 21% | 0,18 0,09 107% | 0,45 0,41 8,8% | 0,21 0,24 -13% | 0,32 | 0,19 |
|
|
| Announcement Date | 07/29/2020 | 10/28/2020 | 02/03/2021 | 04/28/2021 | 07/28/2021 | 10/27/2021 | 02/09/2022 | 04/27/2022 | 07/27/2022 | - | - | - | - | - | |
|
|
Upcoming sector events for GSK PLC |
|
|
|
Past sector events for GSK PLC |
|
|
|
|
|
|
GSK says plaintiffs seeks voluntary dismissal of first Zantac lawsuit |
Net sales (Year) - Rate of surprise
EPS (Year) - Rate of surprise
Net sales (Quarter) - Rate of surprise
EPS (Quarter) - Rate of surprise
|